Published in Women's Health Weekly, November 10th, 2011
"In this study we investigated the value of CTC detection during the first five years of follow-up in predicting late disease relapse. Blood was analyzed from 312 women with operable breast cancer who had not experienced disease relapse during the first two years of follow-up. A real-time reverse...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly